Beijing, China

Yulan Liu

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Yulan Liu: Innovator in Biopharmaceuticals

Introduction

Yulan Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative antibodies. With a total of 3 patents to his name, Liu's work is paving the way for advancements in medical treatments.

Latest Patents

Liu's latest patents include groundbreaking inventions such as the "Anti-IL-4R antibody and use thereof." This patent discloses an antibody or an antigen-binding portion that binds to human IL-4R, along with a polynucleotide encoding the antibody, a vector comprising the polynucleotide, and a method for preparing and purifying the antibody. Another notable patent is the "Bispecific antibody against rabies virus, and application thereof." This invention provides a bispecific antibody that targets different epitopes of the G protein of the rabies virus, demonstrating rabies virus neutralization activity.

Career Highlights

Throughout his career, Yulan Liu has worked with several notable companies, including Beijing Wisdomab Biotechnology Co., Ltd and Genrix (Shanghai) Biopharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in the biopharmaceutical sector.

Collaborations

Liu has collaborated with various professionals in his field, including Zhigang Liu and Jingjing Guo, who is a talented woman in the industry. These collaborations have further enhanced his research and development efforts.

Conclusion

Yulan Liu's innovative work in the field of biopharmaceuticals, particularly through his patents, showcases his commitment to advancing medical science. His contributions are likely to have a lasting impact on the treatment of diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…